97
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Naïve pluripotency is associated with global DNA hypomethylation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Naïve pluripotent embryonic stem (ESCs) cells and embryonic germ (EGCs) cells are derived from the preimplantation epiblast and primordial germ cells (PGCs), respectively. We investigated whether differences exist between ESCs and EGCs in view of their distinct developmental origins. PGCs are programmed to undergo global DNA demethylation; however we find that EGCs exhibit equivalent levels of global DNA methylation to ESCs. Importantly, inhibition of MEK and Gsk3b by 2i conditions leads to a pronounced reduction in DNA methylation in both cell types. This is driven by Prdm14 and is associated with downregulation of Dnmt3a and Dnmt3b. However, genomic imprints are maintained in 2i and we report derivation of EGCs with intact genomic imprints. Collectively, our findings establish that culture in 2i instils a naïve pluripotent state with a distinctive epigenetic configuration that parallels molecular features observed in both the preimplantation epiblast and nascent PGCs.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

          G Martin (1981)
          This report describes the establishment directly from normal preimplantation mouse embryos of a cell line that forms teratocarcinomas when injected into mice. The pluripotency of these embryonic stem cells was demonstrated conclusively by the observation that subclonal cultures, derived from isolated single cells, can differentiate into a wide variety of cell types. Such embryonic stem cells were isolated from inner cell masses of late blastocysts cultured in medium conditioned by an established teratocarcinoma stem cell line. This suggests that such conditioned medium might contain a growth factor that stimulates the proliferation or inhibits the differentiation of normal pluripotent embryonic cells, or both. This method of obtaining embryonic stem cells makes feasible the isolation of pluripotent cells lines from various types of noninbred embryo, including those carrying mutant genes. The availability of such cell lines should made possible new approaches to the study of early mammalian development.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Establishment in culture of pluripotential cells from mouse embryos.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Naive and primed pluripotent states.

              After maternal predetermination gives way to zygotic regulation, a ground state is established within the mammalian embryo. This tabula rasa for embryogenesis is present only transiently in the preimplantation epiblast. Here, we consider how unrestricted cells are first generated and then prepared for lineage commitment. We propose that two phases of pluripotency can be defined: naive and primed. This distinction extends to pluripotent stem cells derived from embryos or by molecular reprogramming ex vivo.
                Bookmark

                Author and article information

                Journal
                101186374
                31761
                Nat Struct Mol Biol
                Nat. Struct. Mol. Biol.
                Nature structural & molecular biology
                1545-9993
                1545-9985
                28 January 2013
                17 February 2013
                March 2013
                01 September 2013
                : 20
                : 3
                : 311-316
                Affiliations
                [1 ]Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK
                [2 ]Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology, University of Cambridge, Cambridge, UK
                [3 ]Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge, UK
                [4 ]Department of Biochemistry University of Cambridge, Cambridge, UK
                [5 ]Medical Research Council, Clinical Sciences Centre, Imperial College London, London, UK
                Author notes
                [6]

                these authors contributed equally to this work

                AUTHOR CONTRIBUTIONS The study was conceived and designed by H.G.L., K.R.M. and P.H. Experiments were performed by H.G.L., K.R.M., A.T., V.E., B.N. and P.H. Bioinformatic analysis was performed by T.C. and K.R.M. Blastocyst injections were performed by W.M. N.G. and J.G.K. provided reagents. A.S. and M.A.S. provided critical feedback. H.G.L., K.R.M. and P.H. wrote the manuscript.

                Article
                EMS51086
                10.1038/nsmb.2510
                3591483
                23416945
                7c7ffa59-d2f9-4317-80ae-4d9b3715aade

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Molecular biology
                Molecular biology

                Comments

                Comment on this article